CLINICAL RESEARCH: MYOCARDIAL INFARCTION
Mobilization of Bone Marrow-Derived Oct-4+ SSEA-4+ Very Small Embryonic-Like Stem Cells in Patients With Acute Myocardial Infarction
Wojciech Wojakowski, MD, PhD*,
Micha Tendera, MD, PhD, FACC*,
Magda Kucia, PhD ,
Ewa Zuba-Surma, PhD ,
Edyta Paczkowska, MD, PhD ,
Joanna Ciosek, MD*,
Maciej Ha asa, MD, PhD ,
Marek Król, MD, PhD ,
Maciej Kazmierski, MD, PhD*,
Pawe Buszman, MD, PhD, FACC*, ,
Andrzej Ocha a, MD, PhD*,
Janina Ratajczak, MD, PhD ,
Bogus aw Machali ski, MD, PhD and
Mariusz Z. Ratajczak, MD, PhD , ,*
* Third Division of Cardiology, Medical University of Silesia, Katowice, Poland
Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky
Department of Pathology and Pathophysiology, Pomeranian Medical University, Szczecin, Poland
American Heart of Poland, Ustron, Poland
Manuscript received April 18, 2008;
revised manuscript received September 2, 2008,
accepted September 8, 2008.
* Reprint requests and correspondence: Dr. Mariusz Z. Ratajczak, University of Louisville, 500 South Floyd Street, Louisville, Kentucky 40202 or Department of Pathology and Pathophysiology, Pomeranian Medical University, 72 Powstancow Wlkp. Str., 70-111 Szczecin, Poland (Email: mzrata01{at}louisville.edu).
Objectives: This study sought to assess of the mobilization of nonhematopoietic very small embryonic-like stem cells (VSELs) in acute myocardial infarction (MI).
Background: Acute MI induces mobilization of bone marrow stem cells. Recently, a rare population of VSELs, expressing markers of embryonic pluripotent stem cells (PSCs), was identified in adult murine bone marrow and human umbilical cord blood.
Methods: Thirty-one patients with acute MI and 30 healthy subjects were enrolled. Blood was sampled on admission, after 24 h, and 5 days later. Erythrocytes were lysed and lin–CD45– VSELs were isolated using a live cell sorting system (FACSAria, Beckton Dickinson, San Jose, California).
Results: In healthy subjects the median number of circulating VSELs was very low (median 0.8 [range 0 to 1.3]) cells/µl. In acute MI, VSELs were mobilized early (median 2.7 [range 0.2 to 3.9] cells/µl; p < 0.001) and remained elevated after 24 h and 5 days (median 4.7 [range 0.2 to 6.4] cells/µl; p < 0.003, and median 2.6 [range 0.3 to 3.6] cells/µl; p < 0.03, respectively). The mobilization of VSEL was significantly reduced in patients older than 50 years and with diabetes in comparison with younger and nondiabetic patients. Circulating VSELs were small (7 to 8 µm) and enriched in the messenger ribonucleic acid of PSC markers (Oct-4, Nanog), cardiac lineage (GATA-4, Nkx2.5/Csx, MEF2C), and endothelial (VE-cadherin) markers. The presence of PSC markers (Oct-4, SSEA-4) and the chemokine receptor CXCR4 in circulating VSELs was confirmed at the protein level by immunofluorescent staining and ImageStream system (Amnis Corporation, Seattle, Washington) analysis.
Conclusions: Acute MI induced mobilization of VSELs expressing pluripotent markers, early cardiac and endothelial markers, and chemokine receptor CXCR4.
Key Words: very small embryonic-like stem cells pluripotent stem cells acute myocardial infarction mobilization
|
Abbreviations and Acronyms
| | BM = bone marrow | | EPC = endothelial progenitor cell | | HSC = hematopoietic stem cell | | LVEF = left ventricular ejection fraction | | MI = myocardial infarction | | MNC = mononuclear cell | | PB = peripheral blood | | PSC = pluripotent stem cell | | RT-PCR = (real-time) reverse transcriptase-polymerase chain reaction | | SDF = stromal-derived factor | | VSEL = very small embryonic-like stem cell |
|
Related Articles
-
A Big Promise From the Very Small: Identification of Circulating Embryonic Stem-Like Pluripotent Cells in Patients With Acute Myocardial Infarction
- Douglas W. Losordo and Raj Kishore
J. Am. Coll. Cardiol. 2009 53: 10-12.
[Full Text]
[PDF]
-
Inside This Issue of JACC
J. Am. Coll. Cardiol. 2009 53: A26.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
J. S. Forrester, R. R. Makkar, and E. Marban
Long-term outcome of stem cell therapy for acute myocardial infarction: right results, wrong reasons.
J. Am. Coll. Cardiol.,
June 16, 2009;
53(24):
2270 - 2272.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tendera and W. Wojakowski
Cell therapy--success does not come easy
Eur. Heart J.,
March 2, 2009;
30(6):
640 - 641.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. Losordo and R. Kishore
A big promise from the very small identification of circulating embryonic stem-like pluripotent cells in patients with acute myocardial infarction.
J. Am. Coll. Cardiol.,
January 6, 2009;
53(1):
10 - 12.
[Full Text]
[PDF]
|
 |
|
|